top of page
gradientForSurfBreak.png

Item List

Aug 18, 2025
Yahoo Finance
Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage

Carlsmed Inc. (NASDAQ:CARL), an AI-powered innovator in spine surgery, is poised for significant growth following key advancements and strong analyst projections.

The company recently secured additional Medicare reimbursement for its aprevo personalized interbody implants for cervical fusion procedures, effective October 1, enhancing its financial outlook.

Recent Posts

Portfolio Company

Carlsmed.png

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Pr ...

Carlsmed

Feb 10, 2026

Portfolio Company

Carlsmed.png

xCures and the Colorectal Cancer Alliance Partner to Support Patient Access and ...

The National Law Review

Feb 5, 2026

Portfolio Company

Carlsmed.png

Vanguards of Health Care: Carlsmed Personalizes Spine with AI ...

Bloomberg

Feb 5, 2026

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page